| DOI | Trouver le DOI : https://doi.org/10.1074/jbc.M111.337196 |
|---|
| Auteur | Rechercher : Cuperlovic-Culf, Miroslava1; Rechercher : Ferguson, Dean; Rechercher : Culf, Adrian; Rechercher : Morin Jr, Pier; Rechercher : Touaibia, Mohamed |
|---|
| Affiliation | - Conseil national de recherches du Canada. Technologies de l'information et des communications
|
|---|
| Format | Texte, Article |
|---|
| Sujet | bioinformatics; glioblastoma; metabolomics; transcriptomics; tumor metabolism |
|---|
| Résumé | Glioblastoma multiforme (GBM) is the most common form of malignant glioma, characterized by unpredictable clinical behaviors that suggest distinct molecular subtypes. With the tumor metabolic phenotype being one of the hallmarks of cancer, we have set upon to investigate whether GBMs show differences in their metabolic profiles. ¹H NMR analysis was performed on metabolite extracts from a selection of nine glioblastoma cell lines. Analysis was performed directly on spectral data and on relative concentrations of metabolites obtained from spectra using a multivariate regression method developed in this work. Both qualitative and quantitative sample clustering have shown that cell lines can be divided into four groups for which the most significantly different metabolites have been determined. Analysis shows that some of the major cancer metabolic markers (such as choline, lactate, and glutamine) have significantly dissimilar concentrations in different GBM groups. The obtained lists of metabolic markers for subgroups were correlated with gene expression data for the same cell lines. Metabolic analysis generally agrees with gene expression measurements, and in several cases, we have shown in detail how the metabolic results can be correlated with the analysis of gene expression. Combined gene expression and metabolomics analysis have shown differential expression of transporters of metabolic markers in these cells as well as some of the major metabolic pathways leading to accumulation of metabolites. Obtained lists of marker metabolites can be leveraged for subtype determination in glioblastomas. |
|---|
| Date de publication | 2012-04-23 |
|---|
| Maison d’édition | American Society for Biochemistry and Molecular Biology |
|---|
| Dans | |
|---|
| Langue | anglais |
|---|
| Publications évaluées par des pairs | Oui |
|---|
| Numéro NPARC | 21269082 |
|---|
| Exporter la notice | Exporter en format RIS |
|---|
| Signaler une correction | Signaler une correction (s'ouvre dans un nouvel onglet) |
|---|
| Identificateur de l’enregistrement | 84a6222c-b0f2-4dfa-8933-b33473b45622 |
|---|
| Enregistrement créé | 2013-12-05 |
|---|
| Enregistrement modifié | 2020-04-21 |
|---|
